These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 12901345

  • 1. A contemporary approach to the diagnosis and management of polycythemia vera.
    Tefferi A.
    Curr Hematol Rep; 2003 May; 2(3):237-41. PubMed ID: 12901345
    [Abstract] [Full Text] [Related]

  • 2. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
    Tefferi A.
    Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
    [Abstract] [Full Text] [Related]

  • 3. Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk-stratification, and management.
    Tefferi A.
    Am J Hematol; 2013 Jun; 88(6):507-16. PubMed ID: 23695894
    [Abstract] [Full Text] [Related]

  • 4. Annual Clinical Updates in Hematological Malignancies: a continuing medical education series: polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management.
    Tefferi A.
    Am J Hematol; 2011 Mar; 86(3):292-301. PubMed ID: 21351120
    [Abstract] [Full Text] [Related]

  • 5. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
    Michiels JJ, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W.
    Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
    [Abstract] [Full Text] [Related]

  • 6. Evidence-based management of polycythemia vera.
    Barbui T, Finazzi G.
    Best Pract Res Clin Haematol; 2006 Apr; 19(3):483-93. PubMed ID: 16781485
    [Abstract] [Full Text] [Related]

  • 7. Risk stratification, staging, and treatment of patients with polycythemia vera: Italian and European collaboration on low-dose aspirin in polycythemia data.
    Finazzi G.
    Semin Thromb Hemost; 2006 Apr; 32(3):276-82. PubMed ID: 16673282
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR.
    Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
    [Abstract] [Full Text] [Related]

  • 9. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ, Berneman Z, Schroyens W, Koudstaal PJ, Lindemans J, Neumann HA, van Vliet HH.
    Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
    [Abstract] [Full Text] [Related]

  • 10. Diagnosis and therapy of polycythemia vera.
    Lengfelder E, Merx K, Hehlmann R.
    Semin Thromb Hemost; 2006 Apr; 32(3):267-75. PubMed ID: 16673281
    [Abstract] [Full Text] [Related]

  • 11. Therapy for polycythemia vera and essential thrombocythemia is driven by the cardiovascular risk.
    Barbui T, Finazzi G.
    Semin Thromb Hemost; 2007 Jun; 33(4):321-9. PubMed ID: 17525889
    [Abstract] [Full Text] [Related]

  • 12. Polycythemia vera: a comprehensive review and clinical recommendations.
    Tefferi A.
    Mayo Clin Proc; 2003 Feb; 78(2):174-94. PubMed ID: 12583529
    [Abstract] [Full Text] [Related]

  • 13. [The risk factors for thrombosis, myelofibrosis and leukemia transformation in patients with polycythemia vera].
    Bai J, Xue YP, Ye L, Yao JF, Zhou CL, Qian LS, Yang RC, Li HY, Zhang HY, Shao ZH.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):685-8. PubMed ID: 18399175
    [Abstract] [Full Text] [Related]

  • 14. Vascular and neoplastic risk in a large cohort of patients with polycythemia vera.
    Marchioli R, Finazzi G, Landolfi R, Kutti J, Gisslinger H, Patrono C, Marilus R, Villegas A, Tognoni G, Barbui T.
    J Clin Oncol; 2005 Apr 01; 23(10):2224-32. PubMed ID: 15710945
    [Abstract] [Full Text] [Related]

  • 15. [Polycythemia vera].
    Rain JD.
    Rev Prat; 2005 Oct 15; 55(15):1659-68. PubMed ID: 16334202
    [Abstract] [Full Text] [Related]

  • 16. Treatment of polycythemia vera.
    Barbui T, Finazzi G.
    Haematologica; 1998 Feb 15; 83(2):143-9. PubMed ID: 9549926
    [Abstract] [Full Text] [Related]

  • 17. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V, Za T, Rossi E, Vannucchi AM, Ruggeri M, Elli E, Micò C, Tieghi A, Cacciola RR, Santoro C, Gerli G, Vianelli N, Guglielmelli P, Pieri L, Scognamiglio F, Rodeghiero F, Pogliani EM, Finazzi G, Gugliotta L, Marchioli R, Leone G, Barbui T, GIMEMA CMD-Working Party.
    Haematologica; 2008 Mar 15; 93(3):372-80. PubMed ID: 18268279
    [Abstract] [Full Text] [Related]

  • 18. Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia.
    Passamonti F, Malabarba L, Orlandi E, Baratè C, Canevari A, Brusamolino E, Bonfichi M, Arcaini L, Caberlon S, Pascutto C, Lazzarino M.
    Haematologica; 2003 Jan 15; 88(1):13-8. PubMed ID: 12551821
    [Abstract] [Full Text] [Related]

  • 19. Expertise-based management in essential thrombocythemia and polycythemia vera.
    Finazzi G, Barbui T.
    Cancer J; 2007 Jan 15; 13(6):372-6. PubMed ID: 18032974
    [Abstract] [Full Text] [Related]

  • 20. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
    Swolin B, Rödjer S, Westin J.
    Ann Hematol; 2008 Jun 15; 87(6):467-74. PubMed ID: 18351338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.